Retatrutide 10 mg
A triple GGG receptor agonist research peptide.
What is Retatrutide?
Retatrutide is a synthetic peptide studied as a triple agonist at the GIP, GLP-1 and glucagon receptors. It is supplied lyophilised in a 10 mg vial for laboratory and in-vitro research use only.
How Retatrutide is studied
As a triple agonist, Retatrutide is studied in metabolic research for activity across three receptor pathways, and is a common comparison point against the dual agonist Tirzepatide.
Specifications
Handling & reconstitution
Retatrutide is supplied as a lyophilised (freeze-dried) powder. For research, reconstitute with bacteriostatic water and store the reconstituted vial refrigerated. Our reconstitution calculator works out units and concentration for any vial size and target. See the guide on reconstituting Retatrutide for a step-by-step.
Frequently asked questions
What is Retatrutide supplied as?
Retatrutide is supplied as a lyophilised powder in a 3 mL vial (10 mg), for laboratory and in-vitro research use only.
How is Retatrutide stored?
Store sealed vials cold (−20 °C) and protected from light. Once reconstituted for research, keep the vial refrigerated.
How fast is delivery in Australia?
Orders ship by tracked express post, 1–3 business days to most Australian addresses. Orders placed before 3pm AEST on a business day ship the same day.
Is Retatrutide for human use?
No. Retatrutide is supplied strictly for laboratory and in-vitro research use and is not for human or veterinary consumption, food, or drug use.